ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SRPT Sarepta Therapeutics Inc New

136.53
1.75 (1.30%)
Feb 23 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 570,786
Bid Price 135.50
Ask Price 142.50
News -
Company Name Stock Ticker Symbol Market Type
Sarepta Therapeutics Inc New SRPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.75 1.30% 136.53 20:00:00
Open Price Low Price High Price Close Price Prev Close
135.00 135.00 137.51 136.53 134.78
Trades Volume VWAP Dollar Volume Avg Volume
13,740 570,786 $ 136.43 $ 77,871,067 -
Last Trade Time Type Quantity Stock Price Currency
18:20:55 51 $ 135.25 USD

Sarepta Therapeutics (SRPT) Options Flow Summary

Overall Flow

Bullish

Net Premium

730k

Calls / Puts

100.00%

Buys / Sells

140.00%

OTM / ITM

85.71%

Sweeps Ratio

0.00%

Sarepta Therapeutics Inc New Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
12.77B 93.55M - 933.01M -703.49M -7.52 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sarepta Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SRPT Message Board. Create One! See More Posts on SRPT Message Board See More Message Board Posts

Historical SRPT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Sarepta Therapeutics Description

Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.

Your Recent History

Delayed Upgrade Clock